Similar Papers

Paper Title
Journal
Date
Author
POS0532 AveRAGE PREDNISOLONE DOSE OF ONLY 1 MG PER DAY WAS RISK FACTOR FOR CLINICAL FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS - NINE-YEAR FINDINGS OF THE TOMORROW STUDY
H Yoshimura ... K Mamoto
-
H Yoshimura, et. al.H Yoshimura ... K Mamoto
19 May 2021
SAT0069 A RAPID3-like index documents superior efficacy of BARICITINIB to ADALIMUMAB and placebo, similar to DAS28 and CDAI in the RA-BEAM clinical trial in patients with rheumatoid arthritis
T Pincus ... Cl Gaich
Annals of the Rheumatic Diseases | VOL. 76
T Pincus, et. al.T Pincus ... Cl Gaich
01 Jun 2017
Prospective Comparison of Angiogenesis-Specific 68Ga-RGD2 PET/CT Imaging Parameters and DAS28-ESR in Rheumatoid Arthritis.
Anwin Joseph Kavanal ... Aman Sharma
Clinical nuclear medicine | VOL. 46
Anwin Joseph Kavanal, et. al.Anwin Joseph Kavanal ... Aman Sharma
30 Mar 2021
Real-world comparative study of drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis.
Kenji Saito ... Kiyoshi Migita
PloS one | VOL. 19
Kenji Saito, et. al.Kenji Saito ... Kiyoshi Migita
01 Jan 2024
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study
Antonio Manzo ... Serena Bugatti
RMD Open | VOL. 11
Antonio Manzo, et. al.Antonio Manzo ... Serena Bugatti
29 Jan 2025
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison
Gustaf Magnus Bruze ... Martin Neovius
RMD Open | VOL. 11
Gustaf Magnus Bruze, et. al.Gustaf Magnus Bruze ... Martin Neovius
29 Jan 2025
Trends in work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs): Data from the German National Database (2010-2022).
Carlo Veltri ... Johanna Callhoff
RMD open | VOL. 11
Carlo Veltri, et. al.Carlo Veltri ... Johanna Callhoff
25 Jan 2025
Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease
Liseth De Wolff ... Hendrika Bootsma
RMD Open | VOL. 11
Liseth De Wolff, et. al.Liseth De Wolff ... Hendrika Bootsma
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.